- Report
- May 2023
- 90 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- December 2022
- 69 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- October 2022
- 240 Pages
Global
From €3249EUR$3,570USD£2,785GBP
- Report
- April 2022
- 210 Pages
Global
From €3145EUR$3,456USD£2,696GBP
- Book
- July 2023
- 1568 Pages
- Book
- July 2015
- 328 Pages
Amphotericin B is an antifungal drug used to treat a variety of fungal infections, including those caused by Candida, Aspergillus, and Cryptococcus species. It is commonly used to treat systemic fungal infections, such as those affecting the lungs, heart, and central nervous system. It is also used to treat fungal infections of the skin, nails, and eyes. Amphotericin B is a polyene macrolide antibiotic, and is the most commonly used antifungal drug in the world. It is available in both intravenous and oral formulations, and is often used in combination with other antifungal drugs.
The Amphotericin B market is a subset of the larger Infectious Diseases Drugs market. It is a highly competitive market, with a number of companies offering Amphotericin B products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more